NUWE Stock Analysis: Buy, Sell, or Hold?
NUWE - Nuwellis, Inc. Common Stock
$3.15
0.01 (0.32%)
▲
5d:
+3229.81%
30d:
+432.99%
90d:
+188.99%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When NUWE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: NUWE is 58.3% above its trading range ($1.99). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: NUWE is 58.3% above its trading range ($1.99). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: NUWE is currently trading at $3.15, which is considered extended relative to its 30-day fair value range of $-0.27 to $1.99.
Technical Outlook: Technically, NUWE is in a downtrend. The price is approaching resistance at $0.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.00 (+249.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NUWE is in a downtrend. The price is approaching resistance at $0.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.00 (+249.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-0.27 -
$1.99
Company Quality Score
48/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
35.3%
All Signals
- BEARISH: Price significantly overextended (+58.3% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: Trading 249.2% below Wall St target ($11.00)
Trading Range Analysis
30-Day Trading Range
$-0.27 -
$1.99
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.13
Resistance Level
$0.99
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.00
Wall Street Target
$11.00
(+249.2%)
Revenue Growth (YoY)
26.2%
Earnings Growth (YoY)
-99.2%
Profit Margin
-217.2%
Share & Embed Analysis
Last updated: July 02, 2026 10:48 PM ET
Data refreshes hourly during market hours. Next update: 11:48 PM
Data refreshes hourly during market hours. Next update: 11:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NUWE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 65 BUY |
